Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Real-world (RW) testing patterns of serum lactate dehydrogenase (LDH) and its prognostic value among patients (pts) with metastatic colorectal cancer (mCRC).
Authors
Heinz-Josef Lenz
Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA
Heinz-Josef Lenz , Orsolya Lunacsek , Helene Ostojic , Xiaoyun Pan , Emmanuelle Dochy , Zdravko Vassilev , Nasreen Khan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 46)
DOI
10.1200/JCO.2024.42.3_suppl.46
Abstract #
46
Poster Bd #
D9
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Characteristics of patients (pts) and prognostic factors across treatment lines (TL) in metastatic colorectal cancer (mCRC): An analysis from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.
First Author: Jean-Baptiste Bachet
Poster
2016 Gastrointestinal Cancers Symposium
Treatment patterns and outcomes in metastatic colorectal cancer (mCRC).
First Author: Thomas H. Cartwright
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Prognostic factors for anti-angiogenic treatment in patients with metastatic colorectal cancer: New insights for an old issue from a single institution experience.
First Author: Eleonora Lai
Poster
2020 Gastrointestinal Cancers Symposium
Treatment of metastatic colorectal cancer (mCRC) according to age.
First Author: Laura Ortega